loaderimg
image

Photometics is developing a cancer treatment using infrared light to perform “Selective Photo-Apoptosis” which triggers programmed cell death in cancer cells. Currently in Phase 1 trials, Photometics is initially targeting basal cell carcinoma, the world’s most common cancer.

Company’s Keywords:

Q How Many Employees Does This Company Have?

<2

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<1400000

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2009

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image